EXHIBIT 32: Rule 13a-14(b) Certification
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of China Aoxing Pharmaceutical Company, Inc. (the “Company”) certifies that:
1. The Annual Report on Form 10-K/A (Amendment No. 1) of the Company for the year ended June 30, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| September 23, 2009 | /s/ Zhenjiang Yue |
| | Zhenjiang Yue, Chief Executive Officer |
| | |
| September 23, 2009 | /s/ Hongyue Hao |
| | Hongyue Hao, Chief Financial Officer |
